ADUS earnings analysis
What we found in ADUS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Addus delivered an 8.0% year-over-year increase in Q2 revenue to $377.417 million and expanded operating margin to 10.3% from 9.4%, with diluted EPS of $1.73. Personal care was the principal growth engine, while hospice margin compression and a 4.8% home-health revenue decline temper the result. Liquidity improved materially, with cash at $99.6 million and revolver debt reduced to $64.3 million, but the filing provided no quantitative outlook.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue and EPS accelerated
- Q2 net service revenue rose 8.0% year over year to $377.417 million from $349.443 million, and increased 3.7% sequentially from $364 million in Q1 2026. Diluted EPS was $1.73, up from $1.36 in Q1 2026 and $1.20 in Q2 2025.
- Operating leverage lifted margins
- Operating income increased 18.4% to $38.942 million, expanding operating margin 90 basis points year over year to 10.3% from 9.4%. Gross margin was 32.2%, down 40 basis points year over year but up 30 basis points sequentially from 31.9%.
- Personal care drove growth
- Personal care revenue grew 10.0% to $295.995 million and segment operating income rose 16.9% to $60.380 million. Billable hours increased 5.6% and revenue per billable hour increased 4.2% to $26.55.
- Cash conversion and collections improved
- Operating cash flow for the first six months increased to $92.376 million from $41.478 million a year earlier. The improvement reflected accounts-receivable collection timing and payroll/accounts-payable timing; DSO improved to 36 days from 38 days at year-end.
- Liquidity strengthened and debt declined
- Cash increased to $99.6 million at June 30 from $81.6 million at December 31, while revolving borrowings fell to $64.3 million from $124.3 million after $60.0 million of repayments. Available revolver capacity was $577.8 million.
- Acquisition funded with low capex intensity
- The May 1 HomeCourt acquisition cost approximately $12.2 million and expanded personal care into Indiana. First-half capital expenditures were only $3.1 million, or about 0.4% of $741.028 million in first-half revenue.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Home health volumes and profit declined
- Home health revenue declined 4.8% to $17.175 million, with visits down 6.5% to 88,516; segment operating income fell 25.0% to $3.287 million. Management attributed the revenue decline primarily to lower patient visits.
- Hospice wage pressure compressed margin
- Hospice revenue grew 3.3% to $64.247 million, but its gross margin fell to 44.0% from 47.9% and operating income declined 18.3% to $12.105 million, primarily due to higher direct wages, taxes, and benefits as a share of revenue.
- Illinois reimbursement concentration persists
- The filing states there were no material changes to previously disclosed risk factors, but reimbursement concentration remains substantial: Illinois represented 32.1% of total revenue and the Illinois Department on Aging represented 17.7%. Illinois' current waiver expires September 30, 2026 unless CMS approves renewal.
- Medicare policy and enrollment constraints
- Medicare represented 93.4% of hospice revenue, while CMS estimates 2026 Medicare payments to home health agencies will decrease 1.3%. CMS also imposed a six-month nationwide moratorium in May 2026 on new Medicare enrollments for hospices and home health agencies.
- Labor costs may outpace reimbursement
- Management cites a tight labor market and inflationary pressure; in Illinois, the direct-service-worker minimum wage is $18.75 per hour, while the Chicago minimum wage increased to $17.05 on July 1, 2026. The company cautioned that reimbursement increases beyond fiscal 2026 may not offset future wage increases.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $1.73
- Gross margin
- 32.2%
- Operating margin
- 10.3%
- Segment
- Personal care: $295.995 million, +10.0% year over year
- Segment
- Hospice: $64.247 million, +3.3% year over year
- Segment
- Home health: $17.175 million, -4.8% year over year
What they said about what is next.
The 10-Q contains no quantitative revenue or EPS outlook. Management discussed reimbursement, labor, Medicaid, and regulatory conditions but did not update numeric guidance.
The filing reads better than the one before it.
What came before.
- 10-Q · May 5, 2026
- Addus HomeCare Corporation reported solid Q1 2026 results with revenue of $363.6 million and EPS of $1.62, marking an 18.1% and 4.128% increase from the prior year respectively. While operating income rose 11.7%, the…
- 10-K · February 24, 2026
- Addus reported 2025 net service revenue of $1,422,530,000 versus $1,154,599,000 in 2024 (a $267,931,000 / +23.2% increase) and net income of $95,910,000 in 2025 versus $73,598,000 in 2024. Growth was driven by the…
- 10-Q · May 7, 2024
- Addus reported revenue of $280.7M for the quarter ended March 31, 2024, up $29.1M (+11.6%) versus the prior-year quarter, with gross profit rising to $88.2M and operating income to $23.6M. Diluted EPS increased to $0.97…
- 10-Q · August 1, 2023
- Addus reported quarterly net service revenue of $259,980,000 (up $23,040,000 or 9.7% vs. $236,940,000 a year ago) and operating income increased to $21,539,000 (from $16,894,000). Diluted EPS rose to $0.91 from $0.70 a…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing ADUS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever